Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma.

Autor: Singh R; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States., Thotakura AK; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States., Alati S; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States., Lisok A; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States., Jiang Z; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States., Merino VF; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States., Minn I; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States., Yadav S; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States., Markowski MC; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, MD, United States., Ged Y; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, MD, United States., Pavlovich CP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, MD, United States., Singla N; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, MD, United States., Solnes LB; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States., Gorin MA; The Milton and Carroll Petrie Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Pomper MG; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.; Department of Radiology, UT Southwestern Medical Center, Dallas, TX, United States., Rowe SP; Department of Radiology, University of North Carolina, Chapel Hill, NC, United States., Banerjee SR; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Sep 10; Vol. 14, pp. 1432286. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024).

Correction to: Hetero-bivalent agents targeting FAP and PSMA.

Autor: Boinapally S; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Lisok A; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Lofland G; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Minn I; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Yan Y; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Jiang Z; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Shin MJ; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Merino VF; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA., Zheng L; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Brayton C; Department of Molecular and Comparative Pathobiology, Baltimore, MD, USA., Pomper MG; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA. mpomper@jhmi.edu.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. mpomper@jhmi.edu., Banerjee SR; Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA. sray9@jhmi.edu.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. sray9@jhmi.edu.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Nov; Vol. 49 (13), pp. 4755.

Role of Endothelial Kinin B1 Receptor on the Membrane Potential of Transgenic Rat Aorta.

Autor: Batista C; Department of Biophysics, Universidade Federal de Sao Paulo, Brazil. jbpesquero@unifesp.br., Sales VM, Merino VF, Bader M, Feres T, Pesquero JB

Publikováno v: Physiological research [Physiol Res] 2022 Aug 31; Vol. 71 (4), pp. 477-487. Date of Electronic Publication: 2022 Jul 28.

CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.

Autor: Yan Y; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Narayan A; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cho S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cheng Z; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Liu JO; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Zhu H; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Wang G; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Wharram B; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Lisok A; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Brummet M; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Saeki H; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Huang T; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Gabrielson K; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gabrielson E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cope L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Kanaan YM; Department of Microbiology, College of Medicine, Howard University, Washington, DC, USA., Afsari A; Department of Pathology, College of Medicine, Howard University, Washington, DC, USA., Naab T; Department of Pathology, College of Medicine, Howard University, Washington, DC, USA., Yfantis HG; Pathology and Laboratory Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, MD, USA., Ambs S; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pomper MG; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sukumar S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. saras@jhmi.edu., Merino VF; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vmerino1@jhmi.edu.

Publikováno v: Oncogene [Oncogene] 2021 Sep; Vol. 40 (38), pp. 5752-5763. Date of Electronic Publication: 2021 Aug 02.

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.

Autor: Ding L; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Su Y; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Deciphera Pharmaceuticals, Waltham, MA, USA., Fassl A; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA., Hinohara K; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Nagoya University Graduate School of Medicine, Nagoya, Japan., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Huh SJ; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; ImmunoGen, Inc, Waltham, MA, USA., Bloushtain-Qimron N; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; EMEA Site Intelligence and Activation, Tel Aviv, Israel., Jovanović B; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Ekram M; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; WuXi NextCODE, Cambridge, MA, USA., Zi X; Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.; Second Military Medical University, Shanghai, 200433, P.R. China., Hines WC; Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.; University of New Mexico School of Medicine, Albuquerque, NM, USA., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Gil Del Alcazar C; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Caulfield RJ; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Bonal DM; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Merino VF; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Choudhury S; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Metamark Genetics Inc, Worcester, MA, USA., Ethington G; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Panos L; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Grant M; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Herlihy W; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Au A; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, 94143, USA., Rosson GD; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Argani P; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Pathology, Harvard Medical School, Boston, MA, 02115, USA.; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Dillon D; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Pathology, Harvard Medical School, Boston, MA, 02115, USA., Allred DC; Department of Pathology, Washington University School of Medicine, St. Louis, MO, 63110, USA., Babski K; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Kim EMH; Sutter Roseville Medical Center, Roseville, CA, 95661, USA.; Cancer Treatment Centers of America, Atlanta, GA, USA., McDonnell CH 3rd; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Wagner J; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Rowberry R; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Bobolis K; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Kleer CG; Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA., Hwang ES; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, 94143, USA.; Duke University, Durham, NC, USA., Blum JL; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Cristea S; Department of Data Science, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health Boston, Boston, MA, 02215, USA.; Department of Stem Cell and Regenerative Biology, Harvard University Cambridge, Cambridge, MA, 02138, USA., Sicinski P; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA., Fan R; Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Sukumar S; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Park SY; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Bissell M; Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA., Yao J; MD Anderson Cancer Center, Houston, TX, 77030, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA. Kornelia_Polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. Kornelia_Polyak@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA. Kornelia_Polyak@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. Kornelia_Polyak@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA. Kornelia_Polyak@dfci.harvard.edu.

Publikováno v: Nature communications [Nat Commun] 2019 Sep 13; Vol. 10 (1), pp. 4182. Date of Electronic Publication: 2019 Sep 13.